Rivastigmine Impurity 13 | CAS 42252-34-6 - Request Quote
Rivastigmine Impurity 13
| SZ CAT No: | SZ-R018044 |
| CAS No | 42252-34-6 |
| Mol.F. | C4H8ClNO |
| Mol.Wt. |
121.6 |
| Inv. Status |
Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Rivastigmine Impurity 13 is chemically Ethyl(methyl)carbamic chloride. Rivastigmine Impurity 13 is supplied with detailed characterization data compliant with regulatory guideline. Rivastigmine Impurity 13 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Rivastigmine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 42252-34-6
Purchase 42252-34-6
Order 42252-34-6
Enquire 42252-34-6
price of 42252-34-6
42252-34-6 Supplier
42252-34-6 Manufacturer
42252-34-6 Exporter
buy high quality Rivastigmine Impurity 13
Purchase Rivastigmine Impurity 13
Rivastigmine Impurity 13 suppliers
Rivastigmine Impurity 13 manufacturers
Rivastigmine Impurity 13 price
Order Rivastigmine Impurity 13
Enquire Rivastigmine Impurity 13
Rivastigmine Impurity 13 cost
Rivastigmine Impurity 13 Supplier
Rivastigmine Impurity 13 Distributor
Rivastigmine Impurity 13 for Method Validation
Rivastigmine Reference Standard
Rivastigmine Impurity 13 for ANDA Filing
Rivastigmine Impurity 13 for Forced Degradation Studies
Rivastigmine Impurity 13 Identification Standards
Rivastigmine Impurity 13 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.